2 Robotics Stocks You’ll Wish You Bought Sooner

Key Concepts

• Physical AI: Artificial intelligence integrated into physical hardware capable of operating in the real world.
• Last-Mile Logistics: The final step of the delivery process from a distribution center to the end user.
• Razor and Blades Business Model: A strategy where a company sells a core product (the "razor") at a lower margin or as an entry point, while generating the bulk of long-term, recurring revenue from high-margin consumables or accessories (the "blades").
• Switching Costs: The costs (financial, training, or operational) that a consumer incurs as a result of changing brands, suppliers, or products.
• GLP-1 Medications: A class of drugs (e.g., Ozempic) that have impacted market sentiment regarding the necessity of certain elective surgeries.

---

1. Serve Robotics (Ticker: SERV) – The High-Growth Small Cap

Serve Robotics focuses on autonomous sidewalk delivery robots, primarily integrated with platforms like Uber Eats.

• Financial Performance: Reported Q1 2026 revenue of $3 million, a 578% year-over-year increase. Notably, $1 million of this revenue was derived from high-margin software services, signaling a shift toward a recurring revenue model.
• Operational Scale: The company has expanded its footprint to 44 cities and currently has approximately 800 robots active daily.
• Strategic Growth: The acquisition of Diligent Robotics allows the company to pivot from food delivery into hospital logistics, diversifying its revenue streams.
• Risk Factors: The company faces significant cash burn, with a quarterly net loss of $49 million. However, management maintains a liquidity cushion of $198 million.
• Key Argument: While the company relies heavily on its partnership with Uber, the relationship is protected by Uber’s status as a strategic equity investor and a technology partnership with NVIDIA, which incentivizes Uber to support Serve’s success rather than compete.

2. Intuitive Surgical (Ticker: ISRG) – The Established Industry Leader

Intuitive Surgical is the dominant player in robotic-assisted surgery, best known for the Da Vinci surgical system.

• Business Model: The company utilizes a "razor and blades" model. While the Da Vinci systems are expensive capital investments, the primary revenue driver is the recurring sale of disposable instruments, accessories, and long-term service contracts.
• Financial Breakdown (Q1): Out of $2.8 billion in total revenue, only $650 million came from system sales. $1.7 billion (roughly 80% of total revenue) was generated from recurring sources like instruments and accessories, which grew over 20% year-over-year.
• Market Position: The company benefits from high switching costs; once a hospital invests in a Da Vinci system and trains its staff, it is unlikely to switch to a competitor.
• Addressing Market Concerns: The stock has faced volatility due to fears that GLP-1 weight-loss drugs would reduce the need for bariatric surgeries. However, the presenters argue this is a market miscalculation, as bariatric procedures represent a small portion of their business, and the company is seeing rapid growth in other areas like thoracic and gynecologic surgery, as well as their ION platform for lung biopsies.

---

Comparison of Methodologies

| Feature | Serve Robotics (SERV) | Intuitive Surgical (ISRG) | | :--- | :--- | :--- | | Market Role | Small-cap disruptor | Established monopoly | | Primary Driver | Scaling hardware/automation | Recurring revenue from consumables | | Risk Profile | High cash burn, scaling risk | Market sentiment/valuation cycles | | Strategic Moat | Strategic partnerships (Uber/NVIDIA) | High switching costs/clinical dominance |

---

Synthesis and Conclusion

The transition toward "Physical AI"—as highlighted by industry leaders like Jensen Huang and Elon Musk—positions robotics and automation as the next major wealth-building frontier. Investors are presented with two distinct paths:

1. The Aggressive Growth Path: Serve Robotics offers high-upside potential for those willing to tolerate the risks associated with a scaling hardware company that is currently burning cash to capture market share in the last-mile delivery space.
2. The Compounding Path: Intuitive Surgical represents a mature, cash-generating monopoly currently trading at a discount. Its reliance on recurring revenue from surgical consumables provides a resilient financial foundation, even amidst broader healthcare sector volatility.

The consensus is that while the "Physical AI" trend is in its early stages, the long-term value lies in companies that can successfully integrate software-driven recurring revenue into physical, real-world applications.